Title

Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis
A Comparative Study in the Clinical and Microbial Efficacy of Topical Besifloxocin Ophthalmic Suspension 0.6% With Erythromycin Ophthalmic Ointment 0.5% BID for the Management of Acute Blepharitis
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Study Participants

    30
This study looks at the improvements in signs and symptoms in patients with inflammation of the lids, blepharitis, using two different FDA approved topical antibiotic agents, Besifloxocin and Erythromycin. It also evaluates the bacterial cultures in these patients for microbiologic evidence of improvement.
This is a pilot project involving thirty patients with a specific form of inflammtion of the lids called anterior blepharitis. The patients are graded for their signs a symptoms and then randomized to receive either topical Besifloxocin or Erythromycin in addition to standard lid hygiene measures. All patients have cultures of their eyelids performed prior to initiating therapy and are followed for four weeks. The antibiotics are used for two weeks following which repeat cultures of the lids are obtained. The patients are followed for one additional week to ensure that there is no recurrence of their symptoms once the antibiotics are discontinued.

Only adult patients (age 18-100)and women who are not of child bearing potential are included in this study. Then patients have to have symptoms and signs of the disease, blepharitis. Patient who are on unstable antibiotic or steroid regimens and those who cannot discontinue contact lens use are not included in this study.
Study Started
Aug 31
2011
Primary Completion
Oct 31
2011
Study Completion
Oct 31
2011
Results Posted
Nov 20
2013
Estimate
Last Update
Dec 19
2013
Estimate

Drug Erythromycin

Topical erythromycin ointment twice a day

Drug Besifloxocin

Topical Besifloxocin twice a day

  • Other names: Besivance

Besifloxocin Active Comparator

Use of topical besifloxocin to treat acute blepharitis

Erythromycin Active Comparator

Topical Erythromycin ointment for treatment of acute blepharitis

Criteria

Inclusion Criteria:Acute blepharitis, age 18-100, Signs and symptoms of blepharitis -

Exclusion Criteria: women of child bearing potential, eye surgery within three months of study, contact lens wear, use of topical or antibacterial agents in past two weeks, use of topical or oral steroids in past two weeks unless stable dosage

-

Summary

Besifloxocin

Erythromycin

All Events

Event Type Organ System Event Term

Improvement in Signs and Symptoms of Blepharitis

Signs and symptoms of blepharitis were scored and determined before and after treatment with two different antibiotics

Besifloxocin

15.0
participants

Erythromycin

15.0
participants

Evaluate Improvement of Bacterial Cultures With Two Different Topical Antibiotics

Compare improvement of microbial cultures (greater inhibition of bacterial growth) with the two antibiotics used to treat blepharitis

Besifloxocin

15.0
participants

Erythromycin

15.0
participants

Total

30
Participants

Age, Continuous

49
years (Mean)
Standard Deviation: 11

Age, Categorical

Region of Enrollment

Sex: Female, Male

Overall Study

Besifloxocin

Erythromycin